Bahl & Gaynor LLC Purchases 19,783 Shares of Ventas, Inc. $VTR

Bahl & Gaynor LLC grew its holdings in shares of Ventas, Inc. (NYSE:VTR) by 2.6% during the third quarter, Holdings Channel reports. The firm owned 786,468 shares of the real estate investment trust’s stock after purchasing an additional 19,783 shares during the period. Bahl & Gaynor LLC’s holdings in Ventas were worth $66,866,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in VTR. Dynamic Wealth Strategies LLC acquired a new stake in Ventas in the 1st quarter worth approximately $25,000. Silvant Capital Management LLC acquired a new position in shares of Ventas in the second quarter valued at $28,000. Heritage Family Offices LLP acquired a new position in Ventas in the third quarter worth about $27,000. Provenance Wealth Advisors LLC raised its stake in Ventas by 640.9% during the third quarter. Provenance Wealth Advisors LLC now owns 326 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 282 shares in the last quarter. Finally, Meeder Asset Management Inc. bought a new position in Ventas during the 2nd quarter valued at about $30,000. 94.18% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have commented on VTR. The Goldman Sachs Group boosted their price objective on Ventas from $110.00 to $114.00 and gave the stock a “buy” rating in a research note on Friday, July 24th. Jefferies Financial Group reduced their price target on Ventas from $102.00 to $95.00 in a research report on Monday, October 12th. Evercore set a $100.00 target price on Ventas and gave the stock an “outperform” rating in a report on Monday, September 21st. Wells Fargo & Company cut their price target on shares of Ventas from $104.00 to $96.00 and set an “overweight” rating on the stock in a research report on Monday, October 19th. Finally, JPMorgan Chase & Co. increased their target price on shares of Ventas from $94.00 to $104.00 and gave the stock an “overweight” rating in a report on Wednesday, September 2nd. Seventeen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $99.41.

Ventas Price Performance

Shares of VTR opened at $90.29 on Wednesday. The stock has a 50 day simple moving average of $86.55 and a 200 day simple moving average of $86.83. Ventas, Inc. has a 52-week low of $73.82 and a 52-week high of $101.60. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.43 and a current ratio of 0.43. The firm has a market capitalization of $47.75 billion, a PE ratio of 23.61, a P/E/G ratio of 3.67 and a beta of 0.77.

Ventas (NYSE:VTR) last announced its earnings results on Tuesday, October 27th. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.98 by ($0.85). Ventas had a return on equity of 1.86% and a net margin of 3.86%. The company had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same quarter last year, the business posted $0.88 earnings per share. The business’s quarterly revenue was up 23.0% on a year-over-year basis. Sell-side analysts predict that Ventas, Inc. will post 3.89 EPS for the current fiscal year.

Ventas Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Wednesday, September 30th were given a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Wednesday, September 30th. Ventas’s payout ratio is currently 392.45%.

Ventas Company Profile

Ventas, Inc. is a real estate investment trust focused on properties and services that support the health care and senior living sectors. Its portfolio includes senior housing communities, outpatient medical buildings, and research and life science facilities. The company owns and invests in properties across the United States, Canada, and the United Kingdom. Many of its communities and facilities are operated by health care and senior living providers, while Ventas provides real estate capital and asset management.